(2S)-2-({1-[(4R,7S,10S,16S,19R)-19-amino-13-[(2S)-butan-2-yl]-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl]pyrrolidin-2-yl}formamido)-N-(carbamoylmethyl)-5-[(diaminomethylidene)amino]pentanamide

• ChemBase编号: 130128
• 分子式: C43H67N15O12S2
• 平均质量: 1050.21538
• 单一同位素质量: 1049.45350466
• SMILES: CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](C(=O)N1)Cc1ccc(cc1)O)N)C(=O)N1CCCC1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
• Canonical SMILES: CC[C@@H](C1NC(=O)[C@@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCCC1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)C
• InChI: InChI=1S/C43H67N15O12S2/c1-3-21(2)34-41(69)53-26(12-13-31(45)60)37(65)55-28(17-32(46)61)38(66)56-29(20-72-71-19-24(44)35(63)54-27(39(67)57-34)16-22-8-10-23(59)11-9-22)42(70)58-15-5-7-30(58)40(68)52-25(6-4-14-50-43(48)49)36(64)51-18-33(47)62/h8-11,21,24-30,34,59H,3-7,12-20,44H2,1-2H3,(H2,45,60)(H2,46,61)(H2,47,62)(H,51,64)(H,52,68)(H,53,69)(H,54,63)(H,55,65)(H,56,66)(H,57,67)(H4,48,49,50)/t21-,24-,25-,26-,27-,28-,29-,30?,34?/m0/s1
• InChIKey: OXDZADMCOWPSOC-ICBIOJHSSA-N

名称和登记号

名称

• IUPAC标准名: (2S)-2-({1-[(4R,7S,10S,16S,19R)-19-amino-13-[(2S)-butan-2-yl]-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl]pyrrolidin-2-yl}formamido)-N-(carbamoylmethyl)-5-[(diaminomethylidene)amino]pentanamide
• IUPAC传统名: vasotocin
• 别名: Argiprestocin; Arg-vasotocin; 8-Arg-vasotocin; Arginine vasotocin; Vasotocin

登记号

• CAS号: 113-80-4
• PubChem SID: 162224412
• PubChem CID: 68649
• 维基百科标题: Vasotocin

理论计算性质

• Acid pKa: 7.6533933
• 质子受体: 16
• 质子供体: 14
• LogD (pH = 5.5): -11.595923
• LogD (pH = 7.4): -9.641374
• Log P: -7.573376
• 摩尔折射率: 261.5708 cm^3
• 极化性: 102.01328 Å^3
• 极化表面积: 463.93 Å^2
• 可自由旋转的化学键: 19
• 里宾斯基五规则: false